This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fincham, J. Search for Related Content Social Bookmarking                         What's this?

A Statewide Program to Stimulate Reporting of Adverse Drug Reactions

Department of Health Care Administration, School of Pharmacy, University of Mississippi, 217-B Faser Hall, University, MS 38677

The purpose of a 26-month Food and Drug Administration sponsored study conducted in Mississippi was to determine how the reporting of adverse drug reactions (ADRs) might be stimulated. The program included both institutional and community based health care facilities located in urban as well as rural settings. Methods used in the study increased the monthly average of reported ADRs from 3.94 to 16.5. Pharmacists have the expertise and responsibility to assume a more active role in the reporting of ADRs.

Journal of Pharmacy Practice, Vol. 2, No. 4, 239-244 (1989)
DOI: 10.1177/089719008900200407


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?